Community-acquired extended-spectrum beta-lactamase producers, United States

Doi, Yohei, Adams, Jennifer, O'Keefe, Alexandra, Quereshi, Zubair, Ewan, Lindsay and Paterson, David L. (2007) Community-acquired extended-spectrum beta-lactamase producers, United States. Emerging Infectious Diseases, 13 7: 1121-1123. doi:10.3201/eid1307.070094

Author Doi, Yohei
Adams, Jennifer
O'Keefe, Alexandra
Quereshi, Zubair
Ewan, Lindsay
Paterson, David L.
Title Community-acquired extended-spectrum beta-lactamase producers, United States
Formatted title
Community-acquired extended-spectrum β-lactamase producers, United States
Journal name Emerging Infectious Diseases   Check publisher's open access policy
ISSN 1080-6040
Publication date 2007-07
Sub-type Letter to editor, brief commentary or brief communication
DOI 10.3201/eid1307.070094
Open Access Status DOI
Volume 13
Issue 7
Start page 1121
End page 1123
Total pages 3
Place of publication Atlanta, GA, United States
Publisher Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Language eng
Subject 110309 Infectious Diseases
110312 Nephrology and Urology
1115 Pharmacology and Pharmaceutical Sciences
Formatted abstract
­To the Editor: Extended-spectrum β-lactamase (ESBL)–producing organisms have become a common problem for patients in hospitals and other healthcare facilities. Community-onset ESBL infections have recently been described in Spain, the United Kingdom, Israel, and Canada. Typically, the infections are urinary tract infections (UTIs) with CTX-M–producing Escherichia coli. These organisms may be resistant to most or all antimicrobial agents commonly used to treat UTIs, such as ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, and ceftriaxone.

Although CTX-M–producing E. coli have previously been found in the United States, clinical descriptions of community-acquired ESBL-producing E. coli infections have not been reported in this country. We describe 2 healthy young women in Pennsylvania in whom UTI with CTX-M-15–producing E. coli developed...
Keyword Extended-spectrum beta-lactamase
Infectious Diseases
Urinary tract
Antibiotic resistance
Extended-spectrum β-lactamase
Q-Index Code CX
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Letter to editor, brief commentary or brief communication
Collections: Excellence in Research Australia (ERA) - Collection
UQ Centre for Clinical Research Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 30 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 18 Feb 2008, 14:16:23 EST